Two trials of AZD7442 will enrol over 6,000 adults for the prevention of COVID-19 with additional trials enrolling ~4,000 adults for the treatment of SARS-CoV-2 infections US Government to invest ~$486m for development and supply of up to 100,000 doses and can acquire another one million doses AstraZeneca’s long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III…
Plastics that can metabolize in oceans are highly sought for a sustainable future. In this work, we report the noncovalent synthesis of unprecedented plastics that…
Nature Human Behaviour – The introduction of mandatory calorie labelling in out-of-home food outlets in England was not associated with a reduction in calories purchased…
Stem cells perceive and respond to biochemical and physical signals to maintain homeostasis. Yet, it remains unclear how stem cells sense mechanical signals from their…
Since 1974 substantial gains in childhood survival have occurred in every global region. We estimate that EPI has provided the single greatest contribution to improved…
Since 1974 substantial gains in childhood survival have occurred in every global region. We estimate that EPI has provided the single greatest contribution to improved…
Weight reduction has been shown to alleviate symptoms of osteoarthritis of the knee, including pain. The effect of glucagon-like peptide-1 receptor agonists on outcomes in…
Stem cells perceive and respond to biochemical and physical signals to maintain homeostasis. Yet, it remains unclear how stem cells sense mechanical signals from their…
CAR-T therapy is generating excitement for lupus, scleroderma, and other conditions as clinical trials expand
SARS-CoV-2 infection can lead to long-lasting neurological sequelae, but underlying mechanisms are unclear. Rong et al. report that SARS-CoV-2 spike protein persists in the skull-meninges-brain axis,…
npj Digital Medicine – Large language models (LLMs) are increasingly applied in medical documentation and have been proposed for clinical decision support. We argue that…
